Camp4 Therapeutics's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics

What is ROE for Camp4 Therapeutics in the third quarter 2026?
Camp4 Therapeutics Corporation recorded a cumulative net loss of $-121 million during 12 months ending in the third quarter 2026, resulting in a negative return on equity (ROE) of -261.83%.

Within the Major Pharmaceutical Preparations industry 346 other companies had a higher return on equity. While return on equity, the total ranking has deteriorated compared to the second quarter 2026 from 3579 to 3773.

What is ROE?

Select the Comparisons :

None ▼

Select the Ratio:

Return on Equity ROE▼

None ▼

Return on Equity ROE▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Equity	(Sep 30 2026) III. Quarter	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter
Y / Y Equity Change	82.55 %	-	-40.08 %	-24.45 %	-
Y / Y Net Income Change	-	-	-	-	-
Net Income (TTM) in Millions	-121	-107	-86	-80	-53
Return On Equity (TTM)	-261.83 %	-314.08 %	-194.74 %	-162.49 %	-100.1 %
CAMP's Total Ranking	# 3773	# 3579	# 3281	# 2227	#
Equity (TTM) in Millions	107	-1	31	48	59
Seq. Equity Change	-	-	-35.22 %	-18.69 %	46.72 %
Seq. Net Income Change	-	-	-	-	-

Back to CAMP Management Effectiveness >> CAMP's 5 Years Annual ROE >> Compare CAMP ROE to its Competitors

Return On Equity Company Ranking
Within:	No.
Industry	# 347
Sector	# 723
Overall	# 3773

Return On Equity Statistics
High	Average	Low
80.78 %	-32.84 %	-314.08 %
(Feb 28 2013)		(Jun 30 2026)

CAMP Annual Return On Equity	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Feb 28 2023) 2023	(Feb 28 2022) 2022	(Feb 28 2021) 2021
Total Equity in Millions	48	63	14	75	95
Y / Y Equity Change	-24.45 %	341.35 %	-81.03 %	-20.7 %	-31.06 %
Net Income in Millions	-80	-52	-32	-28	-56
Y / Y Net Income Change	-	-	-	-	-
Return On Equity	-168.55 %	-82.02 %	-227.09 %	-37.12 %	-59.22 %

Back to CAMP Management Effectiveness >> CAMP's 5 Years Annual ROE >> Compare CAMP ROE to its Competitors

More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
CAMP's' Return on Equity at Yahoo Finance
CAMP's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for CAMP's Competitors
Subscribers only: Roe for Camp4 Therapeutics's Suppliers
Subscribers only: Return On Equity for CAMP's Customers

Companies with similar Return On Equity at Sep 30 2026, within Healthcare Sector

ROE

Date modified: 2026-11-06T06:34:55+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.